| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K80183349 |
| PharmacoGx | BRD-K80183349 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ARPP19 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | PRELID1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | TXNDC16 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | CD274 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | TMEM99 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | MRPL39 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | HOXD13 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | OR5AK2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | GPR39 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | NUMA1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
